Category: Company Technology
Newly funded companies will create jobs, offer medical advancements, and more
PHILADELPHIA, PA (www.sep.benfranklin.org) – Ben Franklin Technology Partners of Southeastern Pennsylvania (BFTP/SEP) recently approved investments totaling $800,000 for five early-stage Pennsylvania companies with promising technology innovations.
“We are encouraged to see the steady flow of early-stage companies during these difficult economic times. We are proud of these five companies for developing innovative technology and creating jobs throughout our region,” said RoseAnn B. Rosenthal, President & CEO of Ben Franklin Technology Partners of Southeastern Pennsylvania.
For Immediate Release: Date: 02/24/10
Contacts:
Massachusetts Life Sciences Center
Angus G. McQuilken, Vice President for Communications
Phone: 617-921-7749 Email: amcquilken@masslifesciences.com
WPI/Gateway Park
Michael Cohen
Phone: 508-868-4778 Email: mcohen@wpi.edu
Grant leverages $25 million private investment for development of a new facility that will create jobs, house young companies and provide training programs in the life sciences
Waltham, MA— The Massachusetts Life Sciences Center Board of Directors today awarded a $6.6 million grant to Worcester Polytechnic Institute (WPI) to support the next phase of life sciences related development at Gateway Park in Worcester. The grant leverages $25 million in private investment for the development of a new 80,000-square-foot life sciences facility anticipated to create 120 construction jobs and 142 new permanent jobs at completion.
The grant supports the development of WPI’s Biomanufacturing Education and Training Center (BETC); a new incubator for Massachusetts Biomedical Initiatives (MBI); and expanded academic and research space, including new facilities for the Massachusetts Academy of Math and Science. The BETC is planning a 10,000-square-foot facility that will provide hands-on biomanufacturing training to support industry workforce development. MBI is planning to expand its incubator resources by developing a new wet-lab core facility to help more companies launch, grow and provide jobs. MBI currently operates three life sciences incubators in Central Massachusetts (one of which is located in the first Gateway Park building) and has graduated 30 companies, creating 265 new jobs since 2000.
 |
|
...But what do I know?
Lessons learned from living through a couple of spin-out companies
|
|
qed@qb3 UCSF
Thursday, March 4, 2010
12:00 to 1:00 pm
Byers Hall Room 212
|
There are many lessons to be learned in the formation of spinouts. Tom will walk through his experiences going from an academic setting to a spinout company and what he has learned from this and a couple of other companies that he has been close to (Avantome, TrueMaterials, Boreal Genomics)
Tom Willis is the CEO of MLC Dx Inc. a VC backed company dedicated to the commercialization of molecular diagnostic tests. Prior to founding MLC, Tom has been an entrepreneur in the biotech industry for the past decade. After receiving his Ph.D. in physics from Stanford University, he joined the Stanford Genome Technology Center (SGTC) to work on DNA sequence analysis technologies. He held several positions at the SGTC including Associate Director in charge of technology development. While at SGTC, he co-invented the Molecular Inversion Probe technology for high throughput genotyping. In 2001, he co-founded ParAllele BioScience to develop and commercialize this technology. As its founding CEO, he led ParAllele through two rounds of VC financing a grew the company to over 80 employees. In 2005 ParAllele was acquired by Affymetrix at which time Tom served in several management positions at Affymetrix. He left in 2007 to pursue new startup opportunities. In addition to his role at MLC, Tom serves on the boards of SpinX Technologies and Boreal Genomics
Lunch provided, but space is limited so please reserve a seat at http://www.acteva.com/booking.cfm?bevaID=198455
http://qb3.org/services/qed-qb3/?searchterm=qed
For Immediate Release: Date: February 11, 2010
Contacts:
Dr. Andrew Fox Angus McQuilken
President & Founder Vice President for Communications
Wadsworth Medical Technologies Massachusetts Life Sciences Center
Cell: 508-789-6531 Cell: 617-921-7749
CEO says he’s “paying it forward” for Life Sciences companies in the state
Westborough, MA – Wadsworth Medical Technologies today announced it has replaced its two out-of-state manufacturers and suppliers with companies based in Massachusetts. The Westborough-based medical device company has hired Baril Corporation of Haverhill and G&F Industries of Sturbridge to produce and distribute DermaLOC, its non-invasive, needleless wound closure system. Wadsworth hopes that its decision will help create jobs in Massachusetts and increase the tax base in these communities.
“The decision to relocate our manufacturing and distribution operations to Massachusetts was a no-brainer,” said Dr. Andrew Fox, President & CEO of Wadsworth Medical Technologies. “There are so many networks within the Commonwealth to support the growth and development of small life sciences companies like Wadsworth that it didn’t make sense to deal out-of-state.”
Last year, Wadsworth Medical Technologies received an Accelerator loan from the Massachusetts Life Sciences Center, a quasi-public agency tasked with stimulating the life sciences sector in Massachusetts. Fox says he sees this decision to support Massachusetts manufacturing and supply companies as a way to “pay it forward.”
Date: February 2, 2010
Time: 11:30AM-2:00PM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Registration Cost: from $0 to $40
The discovery and identification of a new molecular entity (NME) and the application of research required to show a proof-of-principle for a therapeutic agent can be rife with pitfalls and it is extremely difficult to qualify a new prospect for venture funding or partnering with another pharmaceutical company. This event will include discussions around: • Leveraging Drug Metabolism and Pharmacokinetics in Lead Selection and PreClinical Therapeutic Development • Moving From Research To Development: Avoiding The Pitfalls • Effective Partnering with a Contract Research Organization to Optimize Your Drug Development Plan • The Role of Preclinical Safety Assessment in the Drug Development Process. The session will conclude with a panel discussion to provide attendees with the opportunity for valuable exchanges with experts in the fields of drug development and regulatory toxicology. | Registration fee: from $0 to $40 | 11:30-2:00 | @ the San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
FOR IMMEDIATE RELEASE Contact:
Tracey Rice
Ligon Discovery
(617) 453-0952
press@ligondiscovery.com
Broad Institute Spinout is Pursuing Drugs for Intractable Disease Targets
For Release:Contact: Edna Kaplan or Barry Wanger
2:30 p.m., Monday, Nov. 16 Wanger Associates
Barry@WangerAssociates.com
617-965-6469 (office)
617-974-8659 (cell)
Research Opens Door for Developing New Treatments
Boston, MA (November 16, 2009) -- Scientists at Biomodels have successfully
developed the first model that accurately duplicates human cancer
treatment-related fatigue (CTRF).
The Nidus Center for Scientific Enterprise focuses on incubating plant biotechnology and life science businesses in St. Louis, Missouri. Until this summer the Nidus Center had occupied 40,000 square feet on the campus of Monsanto Company’s world headquarters. Recently, the Nidus Center moved to the Danforth Plant Science Center campus's Bio-Research and Development growth Park (BRDG-Park) freeing the previously held offices and lab space for Monsanto to operate.
Philadelphia, PA. November 1, 2009 /BUSINESS WIRE/--Integral Molecular, Inc. has been selected to receive a five year, $9.1 million contract from the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health, to elucidate novel B cell epitopes on the surface of viral pathogens.
Media Release
October 29, 2009
Media inquiries
The Association of University Research Parks (AURP) has honored Medipacs Inc., a Tucson-based company, with its Innovation Award for 2009.
